Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Dellaripa

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 5, 2024
ReplyPaul F Dellaripa
Clinical Immunology (Orlando, Fla.)|September 20, 2017
Interstitial lung disease in the connective tissue diseases; a paradigm shift in diagnosis and treatmentPaul F Dellaripa
Rheumatic Diseases Clinics of North America|April 4, 2015
Demystifying lung disease in the rheumatic diseasesAryeh Fischer, Paul F Dellaripa
Rheumatic Diseases Clinics of North America|April 20, 2013
Extrapulmonary manifestations of sarcoidosisDeepak A Rao, Paul F Dellaripa
Chest|May 30, 2017
Lung Manifestations in the Rheumatic DiseasesTracy J Doyle, Paul F Dellaripa
Current Opinion in Rheumatology|September 21, 2018
Recent progress in systemic sclerosis-interstitial lung diseaseFlavia V Castelino, Paul F Dellaripa
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 18, 2006
Beneficial response to rituximab in refractory Felty SyndromeNicole Weinreb, Arthur Rabinowitz, Paul F Dellaripa
Rheumatic Diseases Clinics of North America|November 20, 2025
The Effects of Extreme Heat on Individuals with Rheumatic Conditions: Equity ConsiderationsAna Valle, Paul F Dellaripa, Candace H Feldman
Rheumatology (Oxford, England)|August 6, 2010
The impact of rheumatological evaluation in the management of patients with interstitial lung diseaseFlavia V Castelino, Hilary Goldberg, Paul F Dellaripa
Arthritis & Rheumatology (Hoboken, N.J.)|February 15, 2024
Pulmonary Damage Biomarkers for Risk of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Enabling Early Detection and Risk StratificationPierre-Antoine Juge, Paul F Dellaripa, Jeffrey A Sparks
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Arthritis & Rheumatology (Hoboken, N.J.)|July 5, 2024
ReplyPaul F Dellaripa
Clinical Immunology (Orlando, Fla.)|September 20, 2017
Interstitial lung disease in the connective tissue diseases; a paradigm shift in diagnosis and treatmentPaul F Dellaripa
Rheumatic Diseases Clinics of North America|April 4, 2015
Demystifying lung disease in the rheumatic diseasesAryeh Fischer, Paul F Dellaripa
Rheumatic Diseases Clinics of North America|April 20, 2013
Extrapulmonary manifestations of sarcoidosisDeepak A Rao, Paul F Dellaripa
Chest|May 30, 2017
Lung Manifestations in the Rheumatic DiseasesTracy J Doyle, Paul F Dellaripa
Current Opinion in Rheumatology|September 21, 2018
Recent progress in systemic sclerosis-interstitial lung diseaseFlavia V Castelino, Paul F Dellaripa
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 18, 2006
Beneficial response to rituximab in refractory Felty SyndromeNicole Weinreb, Arthur Rabinowitz, Paul F Dellaripa
Rheumatic Diseases Clinics of North America|November 20, 2025
The Effects of Extreme Heat on Individuals with Rheumatic Conditions: Equity ConsiderationsAna Valle, Paul F Dellaripa, Candace H Feldman
Rheumatology (Oxford, England)|August 6, 2010
The impact of rheumatological evaluation in the management of patients with interstitial lung diseaseFlavia V Castelino, Hilary Goldberg, Paul F Dellaripa
Arthritis & Rheumatology (Hoboken, N.J.)|February 15, 2024
Pulmonary Damage Biomarkers for Risk of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Enabling Early Detection and Risk StratificationPierre-Antoine Juge, Paul F Dellaripa, Jeffrey A Sparks
Pageof 10